Nicotine Lozenges and Assisted Self-help for Smokeless Tobacco Cessation
LASH
2 other identifiers
interventional
1,067
1 country
1
Brief Summary
This research study will determine if using a combination of 4-mg nicotine lozenges, self-help materials, and/or telephone tobacco cessation counseling will help smokeless tobacco users stop using tobacco. The study will consist of three interventions:
- 1.The Lozenge Assisted Self-help intervention - lozenge nicotine replacement therapy, phone counseling, and self help materials
- 2.Assisted Self-Help intervention - self-help materials and phone counseling without lozenges
- 3.Lozenge Self Help intervention - self help materials and lozenge nicotine replacement therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2011
CompletedFirst Posted
Study publicly available on registry
April 26, 2011
CompletedStudy Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedAugust 4, 2021
July 1, 2021
1.3 years
April 25, 2011
July 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prolonged All Tobacco Abstinence
The primary outcome measure will be self-reported prolonged abstinence from all tobacco use at 3- and 6-month follow-up.
6 months
Secondary Outcomes (1)
Saliva Test for Bio-chemical Verification of Tobacco Abstinence
6 months
Study Arms (3)
Lozenge Self Help: self help materials & lozenge NRT.
ACTIVE COMPARATORSelf-help materials + Commit® nicotine lozenges (4 mg)
Lozenge Assisted Self-help: lozenge NRT, phone counseling, & self help materials
EXPERIMENTALSelf-help materials + Commit® nicotine lozenges (4 mg) + Phone counseling
Assisted Self-Help: self-help materials & phone counseling without lozenges
EXPERIMENTALSelf-help materials + Phone counseling
Interventions
Participants provided with instructions on standard use of lozenge for nicotine replacement therapy (NRT) \& instructed to use the lozenge any time they have a craving or urge to use ST or tobacco. Dosing: weeks 1-6 one lozenge every 1-2 hours/16 per day, weeks 7-9 one lozenge every 2-4 hours/8 per day, weeks 10-12 one lozenge every 4-8 hours/4 per day + The "Enough Snuff" video and printed guide providing strategies for tobacco cessation.
Three phone counseling sessions to assist in cessation from use of all tobacco + lozenge nicotine replacement therapy (NRT) + The "Enough Snuff" video and printed guide providing strategies for tobacco cessation.
Three phone counseling sessions to assist in cessation from use of all tobacco + The "Enough Snuff" video and printed guide providing strategies for tobacco cessation.
Eligibility Criteria
You may qualify if:
- years old or over
- Currently using smokeless tobacco products as primary tobacco product
- Use smokeless tobacco for the last 6 months
- Currently want to quit
- Able to read and write English; and
- Willing to share phone number, e-mail, and mailing address with the research project
- complete informed consent process
You may not qualify if:
- have used behavioral or pharmacologic tobacco treatment in last 30 days
- medical history of unstable angina, myocardial infarction within the past 6 months, cardiac dysrhythmia other than medication-controlled atrial fibrillation or PSVT or medically treated or untreated hypertension with BP ≥ 180 systolic OR ≥ 100 diastolic
- have phenylketonuria (PKU)
- have another member of their household already participating in this study
- currently pregnant or nursing
- score of ≥ 15 on the Patient Health Questionnaire (PHQ-8)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oregon Research Institutelead
- National Cancer Institute (NCI)collaborator
- Mayo Cliniccollaborator
Study Sites (1)
Oregon Research Insititute
Eugene, Oregon, 97403, United States
Related Publications (2)
Ebbert JO, Severson HH, Danaher BG, Benowitz NL, Schroeder DR. Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users. Nicotine Tob Res. 2016 Mar;18(3):366-70. doi: 10.1093/ntr/ntv102. Epub 2015 May 14.
PMID: 25977408RESULTSeverson HH, Danaher BG, Ebbert JO, van Meter N, Lichtenstein E, Widdop C, Crowley R, Akers L, Seeley JR. Randomized trial of nicotine lozenges and phone counseling for smokeless tobacco cessation. Nicotine Tob Res. 2015 Mar;17(3):309-15. doi: 10.1093/ntr/ntu145. Epub 2014 Aug 28.
PMID: 25168034RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Herbert H Severson, PhD
Oregon Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2011
First Posted
April 26, 2011
Study Start
July 1, 2011
Primary Completion
November 1, 2012
Study Completion
November 1, 2012
Last Updated
August 4, 2021
Record last verified: 2021-07